ocr: Figure 3 Estimated Probability of Patients Using Additional Treatments for Migraine Over the 24 Hours Following Either Migranale dimydroergotamine mesylate, USP) Nasal Spray 2 mg (or placebo)* MigranalN=305, Placebo N=300) 100% D 80% - 3 - Placebo - 60% Migranalo - 40% a - 20% * L - à - - - -- - - - - L 0% 0 8 12 16 20 24 Hours After First Spray Kaplan-Meier plot based on data obtained from all studies with patients not using additional treatments censored to 24 hours. All patients received a single treatment of study medication for their migraine attack. The plot also includes patients who ha ...
